Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTITUDE-NASH: Rencofilstat in Stage 3 NASH
NCT05461105Phase 2Completed
- Sponsor
- Hepion Pharmaceuticals
- Start
- Mar 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rencofilstat in Nonalcoholic steatohepatitis (NASH), sponsored by Hepion Pharmaceuticals. Started Mar 2022; status: completed.
02
Drugs
rencofilstat
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05461105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461105.